These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38797692)

  • 1.
    Krishna S; Jung ST; Lee EY
    Crit Rev Biotechnol; 2024 May; ():1-23. PubMed ID: 38797692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Therapeutic Single-Chain Variable Fragments (ScFv) in Pichia pastoris.
    Montoliu-Gaya L; Villegas S
    Methods Mol Biol; 2022; 2313():151-167. PubMed ID: 34478136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbials for the production of monoclonal antibodies and antibody fragments.
    Spadiut O; Capone S; Krainer F; Glieder A; Herwig C
    Trends Biotechnol; 2014 Jan; 32(1):54-60. PubMed ID: 24183828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficient expression of a functional humanized single-chain variable fragment (scFv) antibody against CD22 in Pichia pastoris.
    Zarei N; Vaziri B; Shokrgozar MA; Mahdian R; Fazel R; Khalaj V
    Appl Microbiol Biotechnol; 2014 Dec; 98(24):10023-39. PubMed ID: 25239038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris.
    Schoonooghe S; Kaigorodov V; Zawisza M; Dumolyn C; Haustraete J; Grooten J; Mertens N
    BMC Biotechnol; 2009 Aug; 9():70. PubMed ID: 19671134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, purification and characterization of low-glycosylation influenza neuraminidase in α-1,6-mannosyltransferase defective Pichia pastoris.
    Yang YL; Chang SH; Gong X; Wu J; Liu B
    Mol Biol Rep; 2012 Feb; 39(2):857-64. PubMed ID: 21567198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of Full-Length Antibody by Pichia pastoris.
    Nylen A; Chen MT
    Methods Mol Biol; 2018; 1674():37-48. PubMed ID: 28921426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single chain Fab (scFab) fragment.
    Hust M; Jostock T; Menzel C; Voedisch B; Mohr A; Brenneis M; Kirsch MI; Meier D; Dübel S
    BMC Biotechnol; 2007 Mar; 7():14. PubMed ID: 17346344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in Pichia pastoris of human antibody fragments that neutralize venoms of Mexican scorpions.
    Gómez-Ramírez IV; Corrales-García LL; Possani LD; Riaño-Umbarila L; Becerril B
    Toxicon; 2023 Feb; 223():107012. PubMed ID: 36592762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli.
    Miller KD; Weaver-Feldhaus J; Gray SA; Siegel RW; Feldhaus MJ
    Protein Expr Purif; 2005 Aug; 42(2):255-67. PubMed ID: 15946857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a co-culture system using Escherichia coli and Pichia pastoris (Komagataella phaffii) for valuable alkaloid production.
    Urui M; Yamada Y; Ikeda Y; Nakagawa A; Sato F; Minami H; Shitan N
    Microb Cell Fact; 2021 Oct; 20(1):200. PubMed ID: 34663314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris.
    Gomathinayagam S; Laface D; Houston-Cummings NR; Mangadu R; Moore R; Shandil I; Sharkey N; Li H; Stadheim TA; Zha D
    J Biotechnol; 2015 Aug; 208():13-21. PubMed ID: 26015261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Single-Domain Antibodies in Pichia pastoris.
    Matsuzaki Y; Kajiwara K; Aoki W; Ueda M
    Methods Mol Biol; 2022; 2446():181-203. PubMed ID: 35157274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect.
    Montoliu-Gaya L; Esquerda-Canals G; Bronsoms S; Villegas S
    PLoS One; 2017; 12(8):e0181480. PubMed ID: 28771492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the production of isotopically labelled Fab fragments of therapeutic antibodies in Komagataella phaffii (Pichia pastoris) and Escherichia coli for NMR studies.
    Gagné D; Sarker M; Gingras G; Hodgson DJ; Frahm G; Creskey M; Lorbetskie B; Bigelow S; Wang J; Zhang X; Johnston MJW; Lu H; Aubin Y
    PLoS One; 2023; 18(11):e0294406. PubMed ID: 38019850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
    Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
    Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evaluation of a recombinant fungal immunomodulatory protein from L. rhinocerus produced in P. pastoris and E. coli host expression systems.
    Ejike UC; Chan CJ; Lim CSY; Lim RLH
    Appl Microbiol Biotechnol; 2021 Apr; 105(7):2799-2813. PubMed ID: 33763709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.
    Baghban R; Gargari SL; Rajabibazl M; Nazarian S; Bakherad H
    Biotechnol Appl Biochem; 2016; 63(2):200-5. PubMed ID: 24673401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.